Abstract
Background: Asthma is an umbrella diagnosis encompassing distinct pathophysiological mechanisms. While a global problem, our understanding of the interplay between respiratory microbiology and airway inflammation is largely from populations in high income settings. As a result, treatment approaches align poorly with asthma characteristics in less studied populations. Objective: To identify conserved and geographically distinct relationships between airway inflammation and microbiota characteristics in young people with asthma. Methods: We conducted a cross-sectional study performing inflammatory phenotyping, microbiota analysis, and enumeration of total bacteria, Haemophilus influenzae and Moraxella catarrhalis on 488 induced sputum samples from Brazil (n=68), Ecuador (n=119), Uganda (n=69), New Zealand (n=187), and the United Kingdom (n=45). Microbiological characteristics were compared by country, asthma status, and inflammatory characteristics, adjusting for age and sex. Results: Inflammatory phenotypes and airway microbiota differed between countries, with Uganda characterised by greater neutrophil%, microbial diversity, and bacterial load. Across all countries, microbiota similarity differed by asthma status (P=0.012). Within participants with asthma, microbiota similarity for neutrophilic and eosinophilic phenotypes differed from paucigranulocytic (P<0.001 and P=0.020, respectively) and from each other (P<0.001). Neutrophil% was strongly associated with microbiota composition (P<0.001) and positively associated with bacterial load and opportunistic pathogens (P<0.05). In contrast, eosinophil% was less strongly associated with microbiota similarity (P=0.033), positively associated with Streptococcus (P=0.0009), but not associated with bacterial load (P=0.787). Country-specific associations between sputum inflammation and microbiology were evident. Conclusion: Both airway inflammation and microbiology varied geographically in young people with asthma. Associations between microbiota characteristics and neutrophilic phenotype were conserved.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Marsden Fund (20-MAU-071); European Research Council (668954 and 101020088); New Zealand Health Research Council (15/311, 14/474). SLT is funded by the National Health and Medical Research Council (APP2008625), CRB is funded by a NZ HRC Sir Charles Hercus Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the London School of Hygiene & Tropical Medicine (LSHTM) ethics committee (ref: 9776). Informed consent was obtained from all participants or their parents/carers before taking part.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.